The United Kingdom has rolled out a financial compensation program for individuals and families who have been harmed by the COVID-19 vaccine, despite repeated claims by U.S. corporate media entities denying any negative health impacts of the vaccines created by their largest advertisers.
Under the program, the first payments, which amount to a maximum of almost $150,000, have already been made to family members of individuals injured or killed as a result of the experimental vaccine.
Vikki Spit, whose 48-year-old partner Zion became unwell eight days after receiving the AstraZeneca vaccine and ultimately, is believed to be the first recipient of a sum from the government’s vaccine damage payment scheme (VDPS).
The VPDS will compensate British citizens with a tax-free payment of up to £120,000, or nearly $141,000. Vaccines for roughly 20 diseases are eligible for payments under the program and archives of the British government’s website show that COVID-19 was added between November 2020 and July 2021.
To receive a payment, individuals must demonstrate that a vaccine left them “severely disabled,” which the British government quantifies as at least 60 percent disabled.
“This could be a mental or physical disablement and will be based on medical evidence from the doctors or hospitals involved in your treatment,” explains the application guidelines.
Family members can also apply on behalf of injured individuals, as the British government’s portal explains: “You can also apply for this payment on behalf of someone who has died after becoming severely disabled because of certain vaccinations. You need to be managing their estate to apply.”
So far, the National Health Service (NHS) Business Services Authority, the body that handles the VDPS, confirmed that as of May 2022 it had received 1,681 claims related to COVID-19 vaccines.
“Based on current timescales, once medical records have been sent for assessment, we expect to receive an outcome for most cases from the independent medical assessor within 12 weeks,” explained a spokesperson.
The new program follows controversy over the flawed efficacy of COVID-19 vaccines as well as massive conflicts of interest between pharmaceutical representatives and politicians pushing vaccine mandates.
Government health agencies have also helped obscure data from COVID-19 vaccine trials, which, when released, suggests the vaccines don’t confer the same level of immunity as touted by their advocates in the White House and mainstream media.